GCTK
|
GlucoTrack, Inc.
|
US
|
NASDAQ
|
GLMD
|
Galmed Pharmaceuticals Ltd.
|
US
|
NASDAQ
|
GLS
|
Gelesis Holdings, Inc.
|
US
|
NYSE
|
GMVD
|
G Medical Innovations Holdings Ltd.
|
US
|
NASDAQ
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
INBS
|
Intelligent Bio Solutions Inc.
|
US
|
NASDAQ
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
LMDX
|
LumiraDx Limited
|
US
|
NASDAQ
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
MNKD
|
MannKind Corporation
|
US
|
NASDAQ
|
MODD
|
Modular Medical, Inc.
|
US
|
NASDAQ
|
MRK
|
Merck & Company, Inc.
|
US
|
NYSE
|
MTP
|
Midatech Pharma PLC
|
US
|
NASDAQ
|
NBIX
|
Neurocrine Biosciences, Inc.
|
US
|
NASDAQ
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
NMRD
|
Nemaura Medical Inc.
|
US
|
NASDAQ
|
NURO
|
NeuroMetrix, Inc.
|
US
|
NASDAQ
|